Kratos (KTOS) Form 144 Filed Showing Recent Insider Sales
Rhea-AI Filing Summary
Form 144 filed for Kratos Defense & Security Solutions, Inc. (KTOS). The filing notifies a proposed sale of 7,000 shares of common stock with an aggregate market value of $473,064.09, against a reported 672,219,064 shares outstanding. The approximate sale date is listed as 08/25/2025. The securities were acquired on 01/04/2024 as a share grant from Kratos Defense & Security Solutions, Inc. The filer also reported three recent sales during the past three months: 7,000 shares sold on 05/27/2025 for $259,382.00, 7,000 on 06/30/2025 for $322,396.75, and 7,000 on 07/28/2025 for $409,722.60. The notice includes the standard representation regarding material nonpublic information and signature attestations.
Positive
- Clear transactional disclosure: acquisition date, nature (share grant), broker, quantities and aggregate values are provided
- Recent sales disclosed: three prior sales in the past three months with dates and gross proceeds
Negative
- No 10b5-1 plan date disclosed: the filing does not indicate a trading plan adoption date or instruction under Rule 10b5-1
- Limited context: Form contains only transactional details and no issuer operational or explanatory information
Insights
TL;DR: Routine Rule 144 notice for an insider-originated share grant; recent small, periodic sales disclosed.
The filing documents a proposed sale under Rule 144 of 7,000 shares derived from a share grant dated 01/04/2024. The filer disclosed three prior sales of identical block sizes in the prior three months with rising gross proceeds, indicating sales occurred at varying market prices. The filing contains required issuer, acquisition and sale details and the standard attestation regarding material nonpublic information. No additional disclosures about plans, volume limits, or trading arrangements are provided in the notice.
TL;DR: Disclosure aligns with Rule 144 requirements; information is factual and limited to transactional details.
The notice specifies the origin of the shares (share grant) and prior sale history for the filer. It meets the procedural requirements by listing broker, quantity, and aggregate value for the proposed sale. The filing does not include a 10b5-1 plan adoption date or any representation of reliance on such a plan. There are no issuer-specific operational disclosures in this form, consistent with the form's narrow transactional purpose.
FAQ
What does the Form 144 for KTOS disclose?
How were the 7,000 KTOS shares acquired?
What prior insider sales are reported in the filing?
Which broker is handling the proposed sale?
How many shares outstanding does the filing report for KTOS?